Alberto Alvarez-Larrán works as a consultant Hematologist at the Hematology Department of the Hospital Clínic, in Barcelona, Spain. His scientific interest has been focused on the study of the Ph-negative chronic myeloproliferative neoplasms (MPNs), mainly their natural history, prognosis, thrombotic complications, and treatment. His more important contribution to polycythemia vera was the pivotal study regarding the prognostic value of the criteria for resistance/intolerance to hydroxyurea. He has also studied the diagnostic criteria of polycythemia vera, and the natural evolution of polycythemia vera with specific publications focused on splanchnic vein thrombosis, myelofibrotic transformation, and the dynamics of the JAK2 allele burden. Currently, he is the coordinator of the Spanish registry of patients with polycythemia vera.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)